EcoDrugPlus

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSRFEG00010019681
Gene Symbol: PTGS1
1 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSRFEG00010013243
Gene Symbol: PTGS2
1 Cross references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSRFEG00010021475
Gene Symbol: PSMA1
1 Cross references
249 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSRFEG00010020543
Gene Symbol: PSMA2
1 Cross references
188 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSRFEG00010004363
Gene Symbol: PSMA3
1 Cross references
235 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSRFEG00010015777
Gene Symbol: PSMA4
1 Cross references
250 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSRFEG00010018924
Gene Symbol: PSMA5
1 Cross references
210 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSRFEG00010019679
Gene Symbol: PSMA7
1 Cross references
155 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSRFEG00010021557
Gene Symbol: PSMA8
1 Cross references
197 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSRFEG00010018330
Gene Symbol: PSMB1
1 Cross references
216 Possible Orthologues:

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSRFEG00010018272
Gene Symbol: PSMB10
1 Cross references
171 Possible Orthologues:

Proteasome 20s Subunit Beta 3

Ensembl ID : ENSRFEG00010009823
Gene Symbol: PSMB3
1 Cross references
234 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).